iRhythm Technologies Inc
IRTC188.300USD
+5.090+2.78%
Fechamento 11/25, 16:00（ET）Cotações atrasadas em 15 min
6.06BValor de mercado
PerdaP/L TTM
Mais detalhes de iRhythm Technologies Inc Empresa
iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.
Informações de iRhythm Technologies Inc
Código da empresaIRTC
Nome da EmpresaiRhythm Technologies Inc
Data de listagemOct 20, 2016
CEOMr. Quentin S. Blackford
Número de funcionários2000
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 20
Endereço699 8th Street
CidadeSAN FRANCISCO
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal94103
Telefone14156325700
Sitehttps://www.irhythmtech.com/
Código da empresaIRTC
Data de listagemOct 20, 2016
CEOMr. Quentin S. Blackford
Executivos da empresa iRhythm Technologies Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Quentin S. Blackford
Mr. Quentin S. Blackford
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
63.30K
-18.17%
Ms. Sumi Shrishrimal
Ms. Sumi Shrishrimal
Executive Vice President, Chief Risk Officer
Executive Vice President, Chief Risk Officer
33.78K
-1.90%
Mr. Abhijit Y. (Abhi) Talwalkar
Mr. Abhijit Y. (Abhi) Talwalkar
Independent Chairman of the Board
Independent Chairman of the Board
18.46K
--
Mr. Mervin Smith
Mr. Mervin Smith
Executive Vice President - Business Operations
Executive Vice President - Business Operations
15.84K
-3.74%
Dr. Minang (Mintu) Turakhia, M.D.
Dr. Minang (Mintu) Turakhia, M.D.
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
12.56K
-10.16%
Dr. Ralph Snyderman, M.D.
Dr. Ralph Snyderman, M.D.
Independent Director
Independent Director
11.45K
+13.46%
Mr. Bruce G. Bodaken
Mr. Bruce G. Bodaken
Independent Director
Independent Director
10.80K
+14.39%
Karen Ling ,
Karen Ling ,
Independent Director
Independent Director
7.73K
+21.32%
Mr. Daniel G. (Dan) Wilson
Mr. Daniel G. (Dan) Wilson
Chief Financial Officer
Chief Financial Officer
3.96K
-66.88%
Ms. Karen K. Mcginnis, CPA
Ms. Karen K. Mcginnis, CPA
Independent Director
Independent Director
2.04K
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Quentin S. Blackford
Mr. Quentin S. Blackford
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
63.30K
-18.17%
Ms. Sumi Shrishrimal
Ms. Sumi Shrishrimal
Executive Vice President, Chief Risk Officer
Executive Vice President, Chief Risk Officer
33.78K
-1.90%
Mr. Abhijit Y. (Abhi) Talwalkar
Mr. Abhijit Y. (Abhi) Talwalkar
Independent Chairman of the Board
Independent Chairman of the Board
18.46K
--
Mr. Mervin Smith
Mr. Mervin Smith
Executive Vice President - Business Operations
Executive Vice President - Business Operations
15.84K
-3.74%
Dr. Minang (Mintu) Turakhia, M.D.
Dr. Minang (Mintu) Turakhia, M.D.
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
12.56K
-10.16%
Dr. Ralph Snyderman, M.D.
Dr. Ralph Snyderman, M.D.
Independent Director
Independent Director
11.45K
+13.46%
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Commercial Payors
97.72M
52.34%
Contracted third-party payors
97.72M
52.34%
Centers for Medicare & Medicaid
44.48M
23.83%
Healthcare Institutions
31.83M
17.05%
Non-contracted third-party payors
12.66M
6.78%
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Commercial Payors
97.72M
52.34%
Contracted third-party payors
97.72M
52.34%
Centers for Medicare & Medicaid
44.48M
23.83%
Healthcare Institutions
31.83M
17.05%
Non-contracted third-party payors
12.66M
6.78%
Distribuição de ações
Atualizado em: ter, 18 de nov
Atualizado em: ter, 18 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
10.03%
Artisan Partners Limited Partnership
7.97%
BlackRock Institutional Trust Company, N.A.
7.35%
Sands Capital Management, LLC
6.94%
Capital Research Global Investors
3.67%
Outro
64.04%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
10.03%
Artisan Partners Limited Partnership
7.97%
BlackRock Institutional Trust Company, N.A.
7.35%
Sands Capital Management, LLC
6.94%
Capital Research Global Investors
3.67%
Outro
64.04%
Tipos de investidores
Investidores
Proporção
Investment Advisor
66.24%
Investment Advisor/Hedge Fund
28.39%
Hedge Fund
10.19%
Research Firm
5.20%
Family Office
1.35%
Individual Investor
1.02%
Pension Fund
0.97%
Sovereign Wealth Fund
0.71%
Bank and Trust
0.54%
Participação acionária institucional
Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
609
36.08M
112.00%
-5.27M
2025Q2
586
36.46M
113.50%
-2.59M
2025Q1
586
36.68M
114.94%
-2.13M
2024Q4
571
35.12M
111.82%
-4.41M
2024Q3
584
35.86M
114.62%
-4.91M
2024Q2
581
36.60M
117.28%
-2.20M
2024Q1
578
35.68M
114.75%
-1.24M
2023Q4
542
34.05M
110.03%
-1.99M
2023Q3
543
34.13M
111.64%
-2.86M
2023Q2
537
34.27M
112.49%
-3.29M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
3.23M
10.05%
+127.22K
+4.10%
Jun 30, 2025
Artisan Partners Limited Partnership
2.74M
8.53%
-73.44K
-2.61%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.33M
7.25%
-18.29K
-0.78%
Jun 30, 2025
Sands Capital Management, LLC
2.92M
9.07%
-100.68K
-3.34%
Jun 30, 2025
Capital Research Global Investors
1.51M
4.69%
-695.76K
-31.59%
Jun 30, 2025
Capital World Investors
1.44M
4.47%
+247.00
+0.02%
Aug 31, 2025
State Street Investment Management (US)
868.52K
2.7%
-49.16K
-5.36%
Jun 30, 2025
Geode Capital Management, L.L.C.
767.34K
2.39%
+16.97K
+2.26%
Jun 30, 2025
William Blair & Company, L.L.C. (Research)
739.33K
2.3%
-50.67K
-6.41%
Jun 30, 2025
Eventide Asset Management, LLC
691.57K
2.15%
-48.49K
-6.55%
Jun 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: dom, 2 de nov
Atualizado em: dom, 2 de nov
Nome
Proporção
Global X HealthTech ETF
4.9%
Fidelity Digital Health ETF
2.4%
First Trust Nasdaq Lux Digi Health Solutions ETF
1.9%
Invesco Dorsey Wright Healthcare Momentum ETF
1.72%
ROBO Global Healthcare Technology & Innovation ETF
1.56%
SPDR S&P Health Care Equipment ETF
1.55%
Langar Global HealthTech ETF
1.52%
Goldman Sachs Future Health Care Equity ETF
1.49%
First Trust Multi-Manager Small Cap Opportunities ETF
1.13%
Inspire Fidelis Multi Factor ETF
1.03%
Ver Mais
Global X HealthTech ETF
Proporção4.9%
Fidelity Digital Health ETF
Proporção2.4%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporção1.9%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporção1.72%
ROBO Global Healthcare Technology & Innovation ETF
Proporção1.56%
SPDR S&P Health Care Equipment ETF
Proporção1.55%
Langar Global HealthTech ETF
Proporção1.52%
Goldman Sachs Future Health Care Equity ETF
Proporção1.49%
First Trust Multi-Manager Small Cap Opportunities ETF
Proporção1.13%
Inspire Fidelis Multi Factor ETF
Proporção1.03%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
Perguntas frequentes
Quem são os cinco principais acionistas de iRhythm Technologies Inc?
Os cinco principais acionistas de iRhythm Technologies Inc são:
The Vanguard Group, Inc. detém 3.23M Ações, representando 10.05% do total de Ações.
Artisan Partners Limited Partnership detém 2.74M Ações, representando 8.53% do total de Ações.
BlackRock Institutional Trust Company, N.A. detém 2.33M Ações, representando 7.25% do total de Ações.
Sands Capital Management, LLC detém 2.92M Ações, representando 9.07% do total de Ações.
Capital Research Global Investors detém 1.51M Ações, representando 4.69% do total de Ações.
The Vanguard Group, Inc. detém 3.23M Ações, representando 10.05% do total de Ações.
Artisan Partners Limited Partnership detém 2.74M Ações, representando 8.53% do total de Ações.
BlackRock Institutional Trust Company, N.A. detém 2.33M Ações, representando 7.25% do total de Ações.
Sands Capital Management, LLC detém 2.92M Ações, representando 9.07% do total de Ações.
Capital Research Global Investors detém 1.51M Ações, representando 4.69% do total de Ações.
Quais são os três principais tipos de acionistas de iRhythm Technologies Inc?
Os três principais tipos de acionistas da iRhythm Technologies Inc são:
The Vanguard Group, Inc.
Artisan Partners Limited Partnership
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Artisan Partners Limited Partnership
BlackRock Institutional Trust Company, N.A.
Quantas instituições possuem ações da iRhythm Technologies Inc (IRTC)?
Em 2025Q3, 609 instituições possuíam ações da iRhythm Technologies Inc, com valor de mercado aproximado de 36.08M, representando 112.00% do total de ações. Em comparação com 2025Q2, a participação institucional aumentou em -1.50%.
Qual é a maior fonte de receita da iRhythm Technologies Inc?
Em FY2025Q2, o segmento de negócios Commercial Payors gerou a maior receita para iRhythm Technologies Inc, totalizando 97.72M e representando 52.34% da receita total.
